Lorillard ( LO) estimates raised at UBS through 2011. Expect further price increases in the tobacco industry. Buy rating and $100 price target. Masco ( MAS) estimates lowered at UBS through 2011. Company is realizing higher profitability. Sell rating and $8 price target. Meredith ( MDP) price target lowered at Credit Suisse to $35 from $38. Rate base reductions support circulation thesis. Maintain Neutral rating. McAfee ( MFE) estimates, target cut at Citigroup. Shares of MFE now seen reaching $34. Estimates also lowered, given the company's currency risk. Hold rating. Owens & Minor ( OMI) numbers reduced at UBS. Shares of OMI now seen reaching $29. Estimates also cut, given lower hospital volumes. Neutral rating. Plum Creek ( PCL) target upped at UBS. PCL target was boosted to $39. Company is seeing better operating momentum. Neutral rating. Roper Industries ( ROP) estimates upped at Morgan Stanley through 2012. Company is seeing better results in the Energy and Scientific divisions. Equal-weight rating and $67 price target. Range Resources ( RRC) estimates lowered at UBS through 2011. Company is spending more on exploration. Neutral rating and $52 price target. Sanmina-SCI ( SANM) price target cut at Credit Suisse to $15 from $22. Weak 2Q10 results reveal declining operating leverage. Maintain Neutral rating. SuccessFactors ( SFSF) estimates cut at Morgan Stanley through 2011. Company is focusing on growth, rather than profitability. Equal-weight rating. United Technologies ( UTX) estimate boosted at BofA/Merrill. UTX 2010 EPS estimate jumped to $4.85 from $4.79 on improved operating leverage and performance. Reiterate Buy rating. Veeco Instruments ( VECO) target, estimates raised at BofA/Merrill. VECO price target increased a dollar to $65. 2011 EPS estimate increased to $5.15 on continued strength in the LED cycle. Reiterate Buy rating. Veeco Instruments ( VECO) numbers raised at UBS. Shares of VECO now seen reaching $60. Estimates also increased, given the company's new guidance. Buy rating.